We are live on ! Find out more
ELV icon

Elevance Health

1,419 hedge funds and large institutions have $105B invested in Elevance Health in 2022 Q1 according to their latest regulatory filings, with 149 funds opening new positions, 526 increasing their positions, 486 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 149 | Existing positions closed: 93

29% more funds holding in top 10

Funds holding in top 10: 5166 (+15)

7% more capital invested

Capital invested by funds: $98.4B → $105B (+$6.76B)

3% more funds holding

Funds holding: 1,3731,419 (+46)

1.29% more ownership

Funds ownership: 88.2%89.49% (+1.3%)

8% more repeat investments, than reductions

Existing positions increased: 526 | Existing positions reduced: 486

7% less call options, than puts

Call options by funds: $433M | Put options by funds: $466M

Holders
1,419
Holders Change
+46
Holders Change %
+3.35%
% of All Funds
22.38%
Holding in Top 10
66
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+29.41%
% of All Funds
1.04%
New
149
Increased
526
Reduced
486
Closed
93
Calls
$433M
Puts
$466M
Net Calls
-$33.1M
Net Calls Change
+$100M

ELV Hedge Fund Activity: Q1 2022 in Review

1,419 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2022, worth a combined $105B — up 6.9% from $98.4B a quarter earlier.

Buyers outnumbered sellers: 149 funds opened new ELV positions and 93 closed out — a net gain of 56 holders — while 526 added to existing stakes and 486 trimmed.

The largest buyer was Vanguard Group, adding an estimated $850M. The largest seller was T. Rowe Price Associates, cutting an estimated $479M.

  • 1,419 institutional investors held Elevance Health (ELV) as of Q1 2022, up from 1,373 in Q4 2021.
  • Funds reported $105B of Elevance Health stock for Q1 2022, up 6.9% quarter-over-quarter.
  • 149 funds opened new Elevance Health positions in Q1 2022 and 93 closed out, a net change of +56 holders.
  • The largest Elevance Health buyer in Q1 2022 was Vanguard Group, an estimated $850M added.
  • The largest Elevance Health seller in Q1 2022 was T. Rowe Price Associates, an estimated $479M sold.

Based on aggregated 13F filings for Q1 2022.